Corporate Profile

Main Patents

Patent Contents Application country / Patent number
Cell death inducing agent of prostate cancer cell using REIC / Dkk-3 gene Japan / 4838236
USA / 8658611
Partial fragment of REIC gene and cancer therapeutic agent containing said fragment Japan / 5662534
USA / 8618273, 9475865
Germany · France · UK / 2508606
Cancer cell death inducing agent having anticancer agent enhancing action in anticancer drug-resistant cancer Japan / 5279235
USA / 8946173
Germany · France · UK / 2213309
China / ZL200880122369.2
A pharmaceutical composition for inducing dendritic cell-like differentiation from monocytes and for treating or preventing cancer which enhances anticancer immunity activity USA / 8614093
Germany · France · UK / 2275114
China / ZL20098080116783.7
India / 287896
Malignant mesothelioma therapeutic agent and immunostimulating agent Japan / 5551593
USA / 8658612
Germany · France · UK · Switzerland / 2327779
China / ZL200980136054.8
Gene expression upregulation system and vector Japan / 5697042
USA / 9493776
Germany · France · UK / 2508603
China / ZL201080061897.9
Korea / 10-1752941
Australia / 2010322723
India / 308132
Canada / 2781332
Russia / 2577971
Israel / 219882
Partial region polypeptide of REIC protein Japan / 5936129
USA / 9644013
Germany · France · UK · Italy / 2589658
China / ZL201180041601.1
REIC expressing adenoviral vector Japan / 6014029
USA / 9222107
Taiwan / I 545196
Conditionally replicating adenovirus to express REIC gene Japan / 6566214
USA / 10071126
Germany · France · UK / 3150706
China / ZL201580027897.X
Monitoring for cancer treatment using a specific antibody against REIC/Dkk-3 protein USA / 10782296
A combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor Japan / 6803619
Russia / 2748231
Germany · France · UK / 3400024

As of October 1, 2021